Myriad Genetics, Inc., (NASDAQ:MYGN), a leader in molecular diagnostic testing and precision medicine, announced it will present new data in eight abstracts at the 2025 San Antonio Breast Cancer Symposium® (SABCS).
New data will be presented about Precise® Molecular Residual Disease (MRD) Test and MyRisk® Hereditary Cancer Test
The Campbell Clinic Foundation recently hosted more than 100 students from Cordova, Germantown, and White Station High Schools to Orthopaedic Exploration Day on Friday, November 7 at The Coronet in Memphis.
The Campbell Clinic Foundation recently hosted more than 100 students from Cordova, Germantown, and White Station High Schools to Orthopaedic Exploration Day on Friday, November 7 at The Coronet in Memphis.
The Campbell Clinic Foundation recently hosted more than 100 students from Cordova, Germantown, and White Station High Schools to Orthopaedic Exploration Day on Friday, November 7 at The Coronet in Memphis.
A genetic variant is likely putting some children suffering with myocarditis—inflammation of the heart muscle—at higher risk of developing heart failure, which can be fatal, according to a new study.
A genetic variant is likely putting some children suffering with myocarditis – inflammation of the heart muscle – at higher risk of developing heart failure, which can be fatal, according to a study published today in Circulation Heart Failure.
The findings strongly suggest that genetic testing should be done on all children with heart failure and myocarditis
